Predict your next investment

Biolectrics company logo
HEALTHCARE | Dental Products & Services
biolectrics.net

See what CB Insights has to offer

Founded Year

2008

Stage

Debt | Alive

Total Raised

$6.48M

Last Raised

$520K | 1 yr ago

About Biolectrics

Biolectrics combines medical, biological, and electrical research to develop a new treatment for moderate-to-severe gum disease (periodontal disease) with an oral care device called OraFlow. The OraFlow will be sold through dental offices as a take-home, adjunctive treatment for periodontal disease.

Biolectrics Headquarter Location

1768 E 25th St

Cleveland, Ohio, 44114,

United States

440-940-0200

Latest Biolectrics News

Medical Device Startup Biolectrics Raises Nearly $1M to Eliminate the Pain of Gum Disease

Oct 15, 2015

At-Home Treatment Painlessly Treats Gum Disease CLEVELAND, OH--(Marketwired - Oct 15, 2015) - Dental device startup, Biolectrics, has raised nearly $1 million, about half of its targeted series A fundraise. Biolectrics plans to use the funding to commercialize its pain-free, at-home treatment device, OraFlow®, designed to aide dentists in combatting periodontal disease. According to the American Academy of Periodontology, half of US adults aged 30 and older suffer from periodontal disease. Currently, periodontal disease is treated with in-office dental procedures that can be costly and painful. Due to the expense and pain of current procedures, many patients refuse treatment. Untreated periodontal disease often leads to tooth loss and has recently been associated with atherosclerosis, diabetes, and other systemic health issues. To lead the OraFlow commercialization efforts as CEO, Biolectrics hired dental industry veteran, Steve Cornelius. Mr. Cornelius brings to Biolectrics thirteen years of leadership experience at DENTSPLY International, the world's largest dental products manufacturer, where he was the Vice President and General Manager of the periodontal treatment division. "The OraFlow is a game-changer in the periodontal world. I spent many years at DENTSPLY looking for technologies like OraFlow -- those that could provide dentists a way to help their patients painlessly treat periodontal disease in the convenience of their own home," an energized Cornelius said. The OraFlow is a patented dental device similar in form to an athletic mouth guard and attached to an electronic controller via a cord. The OraFlow provides tiny, painless electrical stimulation to non-invasively kill bacteria associated with periodontal disease. While the exact treatment would be prescribed by a dentist, a typical treatment would only last twenty minutes per day for a few months. Biolectrics has conducted a pilot clinical test on the OraFlow's safety and effectiveness at the Center for Clinical Dental Studies at the University at Buffalo, under the supervision of Dr. Sebastian Ciancio, a Distinguished Service Professor in the School of Dental Medicine. Also, Dr. Ciancio is past president of both the American and International Academies of Periodontology and has authored more than 100 publications on periodontal disease. "Non-surgical periodontal disease treatments haven't changed significantly in recent years. The benefits OraFlow may offer to both dentists and patients are exciting -- a painless device to kill bacteria and improve clinical outcomes in the comfort of the patient's own home," said Ciancio. A pivotal clinical study, again under the direction of Dr. Ciancio, is scheduled to commence later this year. Data from this upcoming study will be used to submit to the US FDA for marketing clearance. For more information on Biolectrics and OraFlow, its innovative oral care device, OraFlow, and the upcoming OraFlow pivotal clinical study please visit biolectrics.net. About Biolectrics Biolectrics is an Ohio limited liability company combining medical, biological, and electrical research to develop a pioneering new treatment for moderate-to-severe gum disease (periodontal disease) with an oral care device called OraFlow. The OraFlow will be sold through dental offices as a take-home, adjunctive treatment for periodontal disease. Biolectrics has tested the OraFlow® clinically and anticipates seeking a marketing clearance from the FDA as early as late 2016. See biolectrics.net for more information. Contact Information

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Biolectrics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Biolectrics is included in 1 Expert Collection, including Dental Health.

D

Dental Health

957 items

Companies delivering dental care products and services. Excludes practice networks.

Biolectrics Patents

Biolectrics has filed 9 patents.

The 3 most popular patent topics include:

  • Conditions of the mucous membranes
  • Oral mucosal pathology
  • Oral hygiene
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/25/2019

3/16/2021

Conditions of the mucous membranes, Inflammations, Oral mucosal pathology, Oral hygiene, Salivary gland pathology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/25/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/16/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Conditions of the mucous membranes, Inflammations, Oral mucosal pathology, Oral hygiene, Salivary gland pathology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.